Skip to main content
Watch Insiders
PTCT filings

Corporate insider profile

Mark Elliott Boulding Filing Activity

Latest reported as EXEC. VP AND CLO of PTC THERAPEUTICS, INC. (PTCT).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,086,769.62
Latest transaction
Oct 9, 2026

Affiliated corporations

Reported company relationships

PTCTLatest reported

PTC THERAPEUTICS, INC.

EXEC. VP AND CLO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 9, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale192$64.26$12,338
Oct 6, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale2,073$64.06$132,791
Aug 17, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale2,813$72.57$204,127
🔒 Unlock Real-Time Alerts and 2 More High-Conviction Rows — Subscribe to Watch Insiders Premium